Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, July 2001, p. 2070-2074, Vol. 45, No. 7
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.7.2070-2074.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Detection of Resistance to Amphotericin B in
Candida Isolates by Using Iso-Sensitest Broth
Manuel
Cuenca-Estrella,*
Teresa M.
Díaz-Guerra,
Emilia
Mellado, and
Juan L.
Rodríguez-Tudela
Centro Nacional de Microbiologia, Instituto
de Salud Carlos III, Madrid, Spain
Received 9 January 2001/Returned for modification 5 February
2001/Accepted 9 April 2001
 |
ABSTRACT |
A major limitation of the National Committee for Clinical
Laboratory Standards M27-A methodology is reliable detection of amphotericin B (AMB) resistance. The results obtained by using Iso-Sensitest, a synthetic medium, to detect AMB resistance were analyzed and compared with those obtained with RPMI and antibiotic medium 3 (AM3). The ability to detect AMB resistance with RPMI is not
enhanced by using a higher inoculum, glucose supplementation at a final
concentration of 20 g/liter, spectrophotometric reading, or 24 h
of incubation time. Testing using AM3 and an inoculum of
103 CFU/ml detects resistance. Identification of resistant
isolates is not improved by glucose supplementation, changes in reading method, or changes in incubation time. However, the use of AM3 as assay
medium and an inoculum of 105 CFU/ml did not allow
detection of AMB resistance. Testing using Iso-Sensitest medium appears
to be similar to AM3 in detecting resistance. The most pronounced
discrimination is achieved by testing in Iso-Sensitest supplemented
with glucose and spectrophotometric reading after 24 h of
incubation. The reproducibility of MIC testing was greatest for
Iso-Sensitest-based procedures. Use of Iso-Sensitest produces both
highly reproducible MICs and reliable identification of
AMB-resistant Candida isolates.
 |
INTRODUCTION |
A great deal of effort has gone into
the development of the standardized method for antifungal
susceptibility testing, and the reference techniques are now more
reliable and reproducible (5, 10). This agreement is
essential for identification of organisms unlikely to respond to
certain antifungal treatments. The National Committee for Clinical
Laboratory Standards (NCCLS) Subcommittee on Antifungal
Susceptibility Testing has standardized testing methods for
Candida spp. and Cryptococcus neoformans
(M27-A;5) and proposed guidelines for filamentous fungi
(M38-P;6). However, the use of the NCCLS methodology
still has some limitations. In particular, a major limitation is the
unreliability of detection of resistance to amphotericin B (AMB). RPMI
medium yields a range of MICs that spans only 3 or 4 twofold
serial dilutions. This short range precludes reliable discrimination
between susceptible and resistant isolates (4, 7,10).
It has been suggested that the utilization of antibiotic medium 3 (AM3) instead of RPMI improves detection of resistance to AMB (9,
14). AM3 used as assay medium allows detection of both
AMB-resistant Candida and Cryptococcus neoformans
isolates (4, 8, 9). In addition, AM3 has shown enhanced
ability to detect resistant isolates by both the dilution procedures of the M27-A reference method and the E-test agar diffusion method (8, 14, 15). However, the reproducibility of antifungal susceptibility testing (AST) using AM3 is still under study. The components of this medium are not completely defined, and substantial lot-to-lot variation has been detected (7, 9). Recent
reports have pointed out that variability was found to be
minimal with currently manufactured lots of AM3
(3). However, other studies have emphasized the potential
for interlaboratory variability when AM3 is used (7). In
addition, it is not clear if glucose supplementation of AM3 decreases
or enhances the ability of AST using this medium to detect AMB
resistance (4).
Variability of antimicrobial susceptibility results is a basic
limitation for the reproducibility of MICs. Thus, some defined or
semidefined synthetic media could be an alternative for detection of
resistance to AMB (10). Iso-Sensitest is a semidefined
medium for antimicrobial susceptibility testing in which undefined
components are kept to a minimum (M. Cuenca-Estrella, J. L. Rodriguez-Tudela, T. M. Diaz-Guerra, and E. Mellado, Abstr. 40th
Intersci. Conf. Antimicrob. Agents Chemother., abstr. J-922, p. 366, 2000). It was designed to overcome the lack of reproducibility with
different peptones. It is made of an aminonitrogen base of
acid-hydrolyzed casein and special peptones supplemented with defined
growth factors including metal ions. Iso-Sensitest medium allows the
growth of the great majority of microorganisms without further
supplementation (2, 13).
The aim of this study was to assess the abilities of Iso-Sensitest to
distinguish amphotericin B-susceptible and -resistant isolates. Results
obtained for two different lots of Iso-Sensitest broth as assay medium
for AST were compared with those obtained by the NCCLS reference
methodology. Results were also compared with both those obtained using
AM3 and those employing RPMI-2% glucose as assay medium for AST. The
influences of inoculum, glucose supplementation, reading method, and
incubation period on MICs of AMB were also analyzed.
(This work was presented in part at the 40th Interscience Conference on
Antimicrobial Agents and Chemotherapy, Toronto, Canada, 2000 [Cuenca-Estrella et al.].)
 |
MATERIALS AND METHODS |
Organisms.
A collection of previously described putatively
AMB-susceptible and -resistant isolates was used (3, 9,
15). Susceptible isolates consisted of four Candida
albicans strains (CNM-CL-3414 [Centro Nacional de Microbiologia
yeast culture collection], CNM-CL-3416, CNM-CL-3419, and CNM-CL-3420),
three Candida parapsilosis strains (ATCC 200954, CNM-CL-3413, and CNM-CL-3417), and one Candida lusitaniae strain (CNM-CL-3418); resistant isolates consisted of four C. lusitaniae strains (ATCC 200950, ATCC 200951, ATCC 200952, and ATCC 200953), one C. albicans strain (ATCC 200955), and one
Candida tropicalis strain (ATCC 200956). Putatively
susceptible isolates either were obtained from the bloodstream from
patients who responded to treatment with AMB or had been proven to be
susceptible in animal models. Putatively resistant organisms had been
proven to be resistant in animal models or showed elevated (>4
µg/ml) MICs of AMB in numerous susceptibility tests.
C. parapsilosis ATCC 22019 and Candida krusei
ATCC 6258 were incorporated as quality control strains in each set of
experiments (5).
AST.
Table 1 lists the methods
evaluated. Two different lots of each medium were employed. Media were
sterilized by filtration and prepared as a double-strength solution.
RPMI, AM3, and Iso-Sensitest were prepared according to the
manufacturers' instructions, and the pH was adjusted to 7.0 with NaOH
or HCl when necessary. Drug stock preparation, storage conditions,
dilution techniques, trays, and inoculum preparations were performed by
the NCCLS reference microdilution method (5). AMB was
obtained as standard powder from Sigma Aldrich Química, Madrid,
Spain.
Sterile plastic microtitration plates containing flat-bottom wells were
utilized. The plates contained twofold serial dilutions
of the
antifungal drugs with 100 µl of assay medium per well.
Two drug-free
medium wells for sterility and growth controls were
employed. Trays
were inoculated with 100 µl of final inocula into
each well. The
microtiter plates were incubated at 35°C for 48
h in a humid
atmosphere. Stationary cultures were performed. The
MICs were
determined at 24 and 48 h both visually and spectrophotometrically
for each assay medium and final inoculum (
1,
11,
12). All
procedures were repeated three times each on different
days.
Endpoint determination.
For visual MIC determination,
endpoints were defined as the lowest concentration of AMB that
completely inhibited the growth of the strain. For spectrophotometric
endpoint determination, the MICs were obtained by measuring the
absorbance at 540 nm with a Labsystems IEMS Reader MF (Labsystems,
Madrid, Spain). The spectrophotometric MIC of AMB was defined as the
lowest drug concentration leading to a 90% or greater growth reduction
compared with the drug-free control (1).
Spectrophotometric reading allowed the determination of the growth
index for each medium-inoculum-incubation time combination. The growth
index was measured relative to the optical density at 540 nm of the
drug-free well serving as the growth control.
Statistical analysis.
The optical density in the drug-free
well must be >0.2 to calculate the spectrophotometric MICs. The mean
absorbance of eight sterility control wells was subtracted from the
absorbance measured for each well, and then spectrophotometric MICs
were calculated. The significance of the differences between methods
was determined by the Student t test (unpaired, unequal
variance) or by the Mann-Whitney U test. When the effect of one
variable was studied, the others were fixed as constants. The
correlation between methods was determined by Pearson's coefficient
expressed over a maximum value of 1. MICs were transformed to
log2 data. A P value of <0.05 was
considered significant.
The reproducibility of the results among media was evaluated by an
intraclass correlation coefficient (ICC) comparing the
results of nine
consecutive determinations of the MICs of AMB
for the two quality
control strains. Reproducibility was calculated
by means of a scales
analysis where reliability was the extent
to which endpoint
determinations yielded the same MICs over time.
The ICC assesses
reliability as an internal consistency statistic
by means of interitem
correlations. A two-way random-effect model
was utilized to calculate
the ICCs that were expressed over a
maximum value of 1 and with a
confidence interval of 95%. All
statistical analyses were done with
SPSS software version 10.0.
 |
RESULTS |
RPMI.
Tables 2 and
3 summarize the AST results obtained by visual reading
and spectrophotometric reading, both after 24 and 48 h of
incubation. The tables list in vitro results for each medium-inoculum combination. It can be noted that AST methods employing RPMI (with or
without glucose) as assay medium failed to detect resistance to AMB.
The MIC ranges for the putatively susceptible and resistant isolates
showed frequent overlaps. No significant differences were found between
visual and spectrophotometric MICs (P > 0.05). Incubation period and inoculum size did not have a significant influence on MICs either.
AM3.
In general, the results for AM3 with or without glucose
were highly correlated with those obtained with RPMI (Pearson's
r coefficients > 0.85). However, the ranges of
observed MICs for putatively susceptible and resistant isolates did not
overlap when an inoculum size of 103 CFU/ml was
employed, permitting discrimination between groups. A reliable
discrimination was not obtained with AM3 and inocula of
105 CFU/ml. A significant inoculum effect was
observed (P < 0.05). Ranges for MICs obtained using an
inoculum size of 105 CFU/ml were more elevated
than those obtained with the lower inoculum. For inocula of
103 CFU/ml, Tables 2 and 3 show that MICs
determined spectrophotometrically and those determined visually, after
24 and 48 h of incubation, were in similar ranges. Glucose
supplementation did not significantly influence MICs (P > 0.05).
Iso-Sensitest.
Methods using Iso-Sensitest as assay medium
yielded AMB MIC ranges broader than both those obtained with RPMI and
those obtained with AM3. In particular, putatively susceptible isolates
demonstrated lower MICs after 24 h of incubation and by
spectrophotometric reading than those obtained with other assay media.
The results achieved with Iso-Sensitest alone and
Iso-Sensitest with glucose showed good correlation indexes
compared with both those obtained with RPMI and those obtained
with AM3 (r > 0.78 and r > 0.83, respectively). Reading method had no significant influence on MIC
determination. However, glucose supplementation, incubation time, and
inoculum size significantly influenced MICs of AMB (P < 0.05). In short, an incubation time of 24 h and an
inoculum of 103 CFU/ml yielded
significantly lower ranges for MICs than those encountered after
48 h of incubation with an inoculum of 105
CFU/ml. The MICs for susceptible isolates fell when AST was
performed with Iso-Sensitest supplemented with glucose, and these
methods showed enhanced abilities to discriminate between putatively
susceptible and resistant isolates (Table
4).
Growth levels for different medium-inoculum-incubation time
combinations.
Table 5 lists growth
indexes for the 14 putatively AMB-susceptible and -resistant isolates
and the two ATCC strains. For each assay medium analyzed, glucose
supplementation and an inoculum size of 105
CFU/ml had additive effect on the growth index (P < 0.05). The best indexes of growth were achieved with Iso-Sensitest
supplemented with glucose. The AM3 medium supplemented with glucose
also yielded luxuriant growth. The lowest growth indexes were obtained
with the NCCLS reference method (RPMI with an inoculum of
103 CFU/ml).
View this table:
[in this window]
[in a new window]
|
TABLE 5.
Growth indices for 14 AMB-susceptible or -resistant
Candida isolates, C. parapsilosis ATCC 22019, and C. krusei ATCC 6258
|
|
Reproducibility.
Table 6 shows
the degree of reproducibility for each method. The table displays
results of nine consecutive MIC determinations for the two ATCC
strains. The ICCs are a reverse measurement of the lot-to-lot
variability of the medium and are expressed over a maximum value of 1. The reproducibility of AMB MICs was high for each method (ICC > 0.723). In general, lower reproducibility was observed with visual
reading than with spectrophotometry. The ICCs of results for AM3 alone
and AM3 with glucose were lower than both those obtained with RPMI
alone or with glucose and those obtained with Iso-Sensitest alone or
with glucose (P < 0.05). The 95% confidence intervals
for AM3 were the broadest, indicating a lower reliability. The highest
ICCs were obtained for Iso-Sensitest (ICC > 0.949).
View this table:
[in this window]
[in a new window]
|
TABLE 6.
Reproducibility of nine consecutive MICs for quality
control strains C. parapsilosis ATCC 22019 and C. krusei ATCC 6258
|
|
 |
DISCUSSION |
Despite its limitations the NCCLS reference method for AST of
yeasts is a new milestone in the evolution of medical mycology. The
good interlaboratory reproducibility of the NCCLS reference methods
has led to the establishment of interpretative breakpoints for
fluconazole, itraconazole, and flucytosine (10). Tentative breakpoints for AMB have not been proposed, however. Evidence of
correlation between the clinical outcome and AMB susceptibility results
is limited due to the lack of a reliable means of detecting resistance
to this antifungal agent employing the reference method (5). Some reports point out that results obtained by
E-test or minimal fungicidal concentration determination are better
predictors of clinical failure of AMB therapy than dilution reference
procedures (4, 7, 8, 15). However, these methods are not
in NCCLS document M27-A, and a more reliable detection of
resistance to AMB is clearly needed.
Several works suggest that with AM3 as assay medium a more reliable
detection of isolates showing AMB resistance is achieved (9). Unfortunately, this medium is not a standardized
medium containing yeast extract, beef extract, and peptone, and
lot-to-lot variation is thus possible (3). Since undefined
media can give rise to widely varying results, the reproducibility of
AST using AM3 is still under study. Some reports have indicated that
AM3 supplemented with glucose enhanced the ability of the medium to detect resistance to AMB in Candida isolates (4,
15). Others found that glucose supplementation decreases the
ability of AM3 to detect AMB resistance. In addition, it is not clear
if results obtained after 24 h of incubation are more accurate
than those obtained after 48 h (8).
A completely synthetic medium is usually recommended for susceptibility
testing. Iso-Sensitest is a semidefined synthetic medium for
antimicrobial susceptibility testing (Cuenca-Estrella et al., 40th
ICAAC). The aim of this work was to test the abilities of Iso-Sensitest
to detect AMB resistance in isolates for which the clinical correlation
was known. The results obtained with Iso-Sensitest were compared with
both those obtained with AM3 and those obtained with RPMI. In addition,
the combined effect of glucose supplementation, reading method, and
inoculum size was also evaluated.
As have other reports, we have confirmed that the NCCLS reference
procedure has a reduced ability to detect AMB resistance (3, 9,
14). The addition of glucose, a higher inoculum size, or the two
modifications together do not help in identifying AMB-resistant
Candida isolates. Neither spectrophotometric reading nor
visual reading permits detection of AMB resistance. Glucose supplementation and a larger inoculum size show an additive effect on
the growth index. This method presents the advantage of reducing incubation time, but AMB resistance is not reliably identified.
In this report, AM3 medium shows an enhanced ability to detect
putatively AMB-resistant organisms. Supplementation with glucose and
reading method do not have a significant influence on MICs obtained
with AM3. However, significant differences are observed in the growth
index. Denser growth indexes are obtained when the medium is
supplemented with glucose than without glucose. In particular, the high
growth index (0.73 + 0.23 U) obtained with AM3-2% glucose and 103 CFU/ml after 24 h of incubation
indicates that the incubation period needed is shorter than that needed
without glucose. In contrast, an inoculum size of
105 CFU/ml does not allow detection of
resistance. A significant inoculum effect is observed when an inoculum
of 105 CFU/ml is used. Thus, the results are
falsely elevated, even the ranges for MICs of putatively susceptible
isolates, and a reliable discrimination is not obtained when AM3 and an
inoculum of 105 CFU/ml are employed. The ICCs for
AM3 are elevated (>0.723), although less than those achieved with both
RPMI and Iso-Sensitest. In general, variability of results with AM3 is
minimally significant, and a reliable detection of resistance to AMB is
observed. As previous studies suggest, isolates for which MICs are
0.25 µg/ml with AM3 medium should be classified as resistant
(3, 4).
Finally, the reproducibility of results with Iso-Sensitest is very
elevated, as expected since this medium is synthetic. Each AST
procedure performed with Iso-Sensitest yielded MIC ranges broader than
those obtained with AM3 and RPMI. However, a reliable detection of
resistance to AMB was seen with ASTs employing Iso-Sensitest-2% glucose only. In particular, the discrimination is better after 24 h of incubation and by spectrophotometric reading. In addition, the
growth indexes with glucose are higher than without glucose, permitting
a reduction in the incubation time. Further, the elevated correlation
observed between results obtained with Iso-Sensitest and both RPMI and
AM3 suggests that the susceptibility testing done with Iso-Sensitest
does not produce an overall shift in MICs but rather reliably
discriminates between AMB-susceptible and -resistant organisms.
In summary, the data presented demonstrate that the glucose
supplementation, a higher inoculum size, the spectrophotometric endpoint determination, and reading after an incubation period of
24 h do not enhance the abilities of AST methods using RPMI as
assay medium to detect AMB resistance. Secondly, susceptibility testing
employing AM3 with an inoculum of 103 CFU/ml
distinguishes between resistant and susceptible isolates. The reading
method, incubation time, and addition of glucose do not have
significant effect on MICs. However, an inoculum size of
105 CFU/ml shows a significant inoculum effect,
and a reliable discrimination is not achieved. Finally, Iso-Sensitest
as assay medium allows detection of AMB resistance. The abilities of
AST using this medium are similar to those of methods employing AM3,
and reproducibility is higher. Because of the small number of strains
tested these findings require further investigation.
 |
ACKNOWLEDGMENTS |
This work was supported in part by research project 99/1199 from
the Instituto de Salud Carlos III. T. M. Díaz-Guerra
is a Fellow of the Instituto de Salud Carlos III (grant 99/4149).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Servicio de
Micología, Centro Nacional de Microbiología, Instituto
de Salud Carlos III, Ctra. Majadahonda-Pozuelo Km. 2, 28220 Majadahonda
(Madrid), Spain. Phone: 34-91-5097961. Fax: 34-91-5097966. E-mail:
mcuenca-estrella{at}isciii.es.
 |
REFERENCES |
| 1.
|
Cuenca-Estrella, M.,
T. M. Diaz-Guerra,
E. Mellado, and J. L. Rodriguez-Tudela.
2001.
Influence of glucose supplementation and inoculum size on the growth kinetics and antifungal susceptibility testing of Candida spp.
J. Clin. Microbiol.
39:525-532[Abstract/Free Full Text].
|
| 2.
|
Koeth, L. M.,
A. King,
H. Knight,
J. May,
L. A. Miller,
I. Phillips, and J. A. Poupard.
2000.
Comparison of cation-adjusted Mueller-Hinton broth with Iso-Sensitest broth for the NCCLS broth microdilution method.
J. Antimicrob. Chemother.
46:369-376[Abstract/Free Full Text].
|
| 3.
|
Lozano-Chiu, M.,
P. W. Nelson,
M. Lancaster,
M. A. Pfaller, and J. H. Rex.
1997.
Lot-to-lot variability of antibiotic medium 3 used for testing susceptibility of Candida isolates to amphotericin B.
J. Clin. Microbiol.
35:270-272[Abstract].
|
| 4.
|
Lozano-Chiu, M.,
V. L. Paetznick,
M. A. Ghannoum, and J. H. Rex.
1998.
Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies.
J. Clin. Microbiol.
36:2817-2822[Abstract/Free Full Text].
|
| 5.
|
National Committee for Clinical Laboratory Standards.
1997.
Reference method for broth dilution antifungal susceptibility testing of yeasts.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 6.
|
National Committee for Clinical Laboratory Standards.
1998.
Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi; proposed standard.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 7.
|
Nguyen, M. H.,
C. J. Clancy,
V. L. Yu,
Y. C. Yu,
A. J. Morris,
D. R. Snydman,
D. A. Sutton, and M. G. Rinaldi.
1998.
Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.
J. Infect. Dis.
177:425-430[Medline].
|
| 8.
|
Pfaller, M. A.,
S. A. Messer, and A. Bolmstrom.
1998.
Evaluation of E-test for determining in vitro susceptibility of yeast isolates to amphotericin B.
Diagn. Microbiol. Infect. Dis.
32:223-227[CrossRef][Medline].
|
| 9.
|
Rex, J. H.,
C. R. Cooper, Jr.,
W. G. Merz,
J. N. Galgiani, and E. J. Anaissie.
1995.
Detection of amphotericin B-resistant Candida isolates in a broth-based system.
Antimicrob. Agents Chemother.
39:906-909[Abstract].
|
| 10.
|
Rex, J. H.,
M. A. Pfaller,
J. N. Galgiani,
M. S. Bartlett,
A. Espinel-Ingroff,
M. A. Ghannoum,
M. Lancaster,
F. C. Odds,
M. G. Rinaldi,
T. J. Walsh, and A. L. Barry.
1997.
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.
Clin. Infect. Dis.
24:235-247[Medline].
|
| 11.
|
Rodriguez-Tudela, J. L., and J. V. Martinez-Suarez.
1994.
Improved medium for fluconazole susceptibility testing of Candida albicans.
Antimicrob. Agents Chemother.
38:45-48[Abstract/Free Full Text].
|
| 12.
|
Rodriguez-Tudela, J. L., and J. V. Martinez-Suarez.
1995.
Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria.
J. Antimicrob. Chemother.
35:739-749[Abstract/Free Full Text].
|
| 13.
|
Traub, W. H.,
U. Geipel, and B. Leonhard.
1998.
Antibiotic susceptibility testing (agar disk diffusion and agar dilution) of clinical isolates of Enterococcus faecalis and E. faecium: comparison of Mueller-Hinton, Iso-Sensitest, and Wilkins-Chalgren agar media.
Chemotherapy
44:217-229[CrossRef][Medline].
|
| 14.
|
Villareal, K. M.,
R. A. Cook,
J. N. Galgiani,
R. P. Wenzel,
P. G. Pappas,
J. C. Pottage, Jr.,
H. A. Gallis, and L. R. Crane.
1994.
Comparative analysis of three antifungal susceptibility test methods against prospectively collected Candida species.
Diagn. Microbiol. Infect. Dis.
18:89-94[CrossRef][Medline].
|
| 15.
|
Wanger, A.,
K. Mills,
P. W. Nelson, and J. H. Rex.
1995.
Comparison of E-test and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates.
Antimicrob. Agents Chemother.
39:2520-2522[Abstract].
|
Antimicrobial Agents and Chemotherapy, July 2001, p. 2070-2074, Vol. 45, No. 7
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.7.2070-2074.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Fries, B. C., Cook, E., Wang, X., Casadevall, A.
(2005). Effects of Antifungal Interventions on the Outcome of Experimental Infections with Phenotypic Switch Variants of Cryptococcus neoformans. Antimicrob. Agents Chemother.
49: 350-357
[Abstract]
[Full Text]
-
Chaturvedi, V., Ramani, R., Rex, J. H.
(2004). Collaborative Study of Antibiotic Medium 3 and Flow Cytometry for Identification of Amphotericin B-Resistant Candida Isolates. J. Clin. Microbiol.
42: 2252-2254
[Abstract]
[Full Text]
-
Rodero, L., Cuenca-Estrella, M., Cordoba, S., Cahn, P., Davel, G., Kaufman, S., Guelfand, L., Rodriguez-Tudela, J. L.
(2002). Transient Fungemia Caused by an Amphotericin B-Resistant Isolate of Candida haemulonii. J. Clin. Microbiol.
40: 2266-2269
[Abstract]
[Full Text]